Immune checkpoint inhibitor-related molecular markers predict prognosis in extrahepatic cholangiocarcinoma.

Bao JinYuxin WangBaoluhe ZhangHaifeng XuXin Lu Xin-Ting SangWenze WangYilei MaoPengxiao ChenShun WangZhirong QianYingyi Wang Shun-Da Du

Published in: Cancer medicine (2023)

TMB and MSI are potential biomarkers associated with better prognosis for EHCC patients. Furthermore, our study highlights important genetic alteration and potential therapeutic targets in EHCC.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
patient reported outcomes
genome wide
risk assessment
dna methylation
single molecule
human health